Advanced Search

National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 7) (PB 57 of 2014)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
PB 57 of 2014
 
National Health Determination under paragraph 98C(1)(b) Amendment 2014
(No. 7)
_____________________________________________________________________
 
 
I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 14 July 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PAUL CREECH
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 7).
(2)                This Instrument may also be cited as PB 57 of 2014.
2              Commencement                                                        
                This instrument commences on 1 August 2014.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 4, after entry for Aciclovir
insert:
Aclidinium
Powder for oral inhalation in breath actuated device containing aclidinium bromide 400 micrograms per dose, 60 doses
[2]        Schedule 4, after entry for Benzydamine
insert:
Betaine
Oral powder 180 g